AVXL vs MA · $247.4M cap vs P/E 38, rev $17.68B
Anavex Life Sciences Corp (AVXL) versus Mastercard Inc (MA) — a side-by-side from cached financials, not a winner call.
Anavex Life Sciences Corp (AVXL) is a biotechnology company listed on NASDAQ.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
AVXL does not have a complete income-statement cache yet.
Latest reported MA revenue for 2026-06-30 was $17.68B. Net income was $8.27B. MA currently screens at market cap $515.12B and trailing P/E 38.4.
AVXL currently screens at market cap $247.4M. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Not investment advice. Open the AVXL and MA stock pages for the full models.
Not investment advice.